Stay updated on CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial
Sign up to get notified when there's something new on the CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial page.
Latest updates to the CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial page
- Check2 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.8%
- Check9 days agoChange DetectedDifference0.6%
- Check16 days agoChange DetectedThe website has been updated with new additions including the latest revision v2.14.1 and several recent dates, while the previous revision v2.14.0 and older update dates have been removed.SummaryDifference0.6%
- Check23 days agoChange DetectedThe website has updated the type of intervention and added contact information for the National Cancer Institute Referral Office, while removing the previous version's details.SummaryDifference1%
- Check31 days agoChange DetectedDifference0.6%
- Check38 days agoChange DetectedDifference0.5%
Stay in the know with updates to CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial page.